ClinicalTrials.gg
RecruitingNCT06268236Updated Nov 18, 2026

Electro-acupuncture to Treat Disorder of Consciousness

An interventional study of Electroacupuncture and Sham electroacupuncture in Disorder of Consciousness and Electroacupuncture, sponsored by The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 10 months later.
Updated Nov 18, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 70 studies in Consciousness Disorders with a site in China — 30 open to participants now, 31 under way, 1 of them phase 3. Consciousness Disorders · China.

Planned enrollment
22nd of 40
50 · median 60
Started
2024
with 9 others
No phase
36 of 70
18 open now
Primary completion
2026-12
later than 18 of 30 live
Registered
45th of 70
by date

Among the 70 studies in Consciousness Disorders with a site in China, this one is the 22nd largest by planned enrollment of the 40 interventional ones that give a count, is one of 10 that started in 2024, is one of 36 with no phase, reaches primary completion later than 18 of the 30 other live ones, and was the 45th registered.

Consciousness Disorders

291 studies on the registry are indexed under Consciousness Disorders; 109 are open to participants now.

Browse Consciousness Disorders studies →

Open to participants now

30 of the 70 studies in Consciousness Disorders with a site in China are open now. Recruiting first, the newest first:

24 more — sign in →

All 30 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 74 Consciousness Disorders studies recruiting now, 31 (42%) set no upper age limit and 24 (32%) stop at 75 or younger; 12 take children under 18; 15 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Consciousness Disorders with a site in China, or all of them as a file.
02

Study summary

With the rapid development of life support technology, more and more people can survive severe brain injury. Some survivors regain consciousness after a period of coma, however, many patients develop prolonged disorders of consciousness (DOC), which poses a therapeutic challenge for clinicians and a heavy burden for their families. The investigators design an Electro-acupuncture to treat disorder of consciousness (AcuDoc) trial with the aim of validating the clinical effect of electroacupuncture in treating DOC and exploring its therapeutic mechanisms by integrating EEG, neuroimaging, evoked potential tests, and behavioral assessments.

Read the detailed description

The AcuDoc trial is a single-center, prospective, triple masking, randomized, sham electroacupuncture-controlled study. A total of 50 adult patients with DOC and 25 healthy subjects will be enrolled in the study . Patients will be randomized into electroacupuncture (EA) group or sham EA group (1:1). All patients will receive EA or sham-EA treatment in the supine position at 9 am for 30 minutes once a day for consecutive 14 days and healthy subjects will receive no treatments. The primary objective is to determine the therapeutic benefit of electroacupuncture on the recovery of consciousness in patients with DOC after a 2-week intervention. Key secondary objective is to investigate the effect of electroacupuncture on the circuitry of consciousness using a multimodal approach integrating EEG, neuroimaging (rs-fMRI, amide proton transfer imaging, intravoxel incoherent motion imaging, neurite orientation dispersion and density imaging), and evoked potentials (SEP, BAEP). Other secondary outcomes include the effect of EA on the assessment of brain-computer interface after a 2-week intervention and on the Glasgow Outcome Scale-Extended score at 30 days and 90 days .

03

Conditions studied

  • Disorder of Consciousness
  • Electroacupuncture

Keywords

  • Acute brain injury
  • Disorder of consciousness
  • Electro-acupuncture
  • Awakening
  • Brain functional network
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥ 18 years;
  2. With cerebral damage due to TBI;
  3. Diagnosed with UWS or MCS based on at least two CRS-R assessments;
  4. From 4 to 16 weeks from the onset of brain injury;
  5. obtained.

Exclusion criteria

Exclusion Criteria:

  1. With a history of neurological or psychiatric disorder prior to the brain injury;
  2. With uncontrolled seizures or status epilepticus;
  3. Unstable vital signs and requiring the use of vasoactive agents;
  4. With the use of general anesthetics or central acting sedative;
  5. Without intact skin at acupoints or sham points;
  6. Concomitant medical illness that would interfere with the outcome assessments and/or follow-up
  7. Pregnant patients;
  8. Currently participating in other trials;
  9. High likelihood of not adhering to the study treatment or the follow-up regimen
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Electro-acupuncture group

    Patients in EA group receive acupuncture at Shuigou (also known as Renzhong, GV26) and Yintang (updated number GV24+, previous number GV29). Paired electrodes from the EA apparatus are clipped to the needle handles at Shuigou and Yintang. The electroacupuncture stimulation lasts for 30 minutes with a wave of rarefaction and condensation (10 Hz / 50 Hz) and a current intensity of the maximum withstand current within 7mA. All patients receive EA at 9 am for 30 minutes once a day for consecutive 14 days.

    Other: Electroacupuncture

  • Sham comparator
    Sham electro-acupuncture group

    Patients in sham-EA group receive sham-EA at sham-Shuigou and sham-Yintang.Acupuncture needles are inserted into the adhesive pads but do not pierce the skin. Paired electrodes from the EA apparatus via sham connecting cords are clipped to the needle handles at sham-Shuigou and sham-Yintang. The sham connecting cords are similar in appearance to the normal ones, but the inner wires in sham connecting cords are cut off and cannot conduct electricity. All patients receive sham-EA at 9 am for 30 minutes once a day for consecutive 14 days.

    Other: Sham electroacupuncture

Interventions

  • OtherElectroacupuncture

    Electro-acupuncture at Shuigou and Yintang.

  • OtherSham electroacupuncture

    Sham-EA at sham-Shuigou and sham-Yintang.

06

What researchers measure

Primary outcomes

  1. Coma Recovery Scale - Revised score

    0 - 23, a higher score indicates a better level of consciousness

    Time frame: after 14 days of EA or sham-EA treatment

Secondary outcomes

  1. phase locking value

    measured by electroencephalogram

    Time frame: after 14 days of EA or sham-EA treatment

  2. amplitude of low-frequency fluctuation

    measured by resting-state functional magnetic resonance imaging

    Time frame: after 14 days of EA or sham-EA treatment

  3. Amide proton transfer-weighted signal

    measured by amide proton transfer imaging

    Time frame: after 14 days of EA or sham-EA treatment

  4. f value

    measured by intravoxel incoherent motion imaging

    Time frame: after 14 days of EA or sham-EA treatment

  5. neurite density index

    measured by neurite orientation dispersion and density imaging

    Time frame: after 14 days of EA or sham-EA treatment

  6. latency value of N20

    measured by somatosensory evoked potential biomarkers

    Time frame: after 14 days of EA or sham-EA treatment

  7. latency between III and V potentials

    measured by brainstem auditory evoked potential

    Time frame: after 14 days of EA or sham-EA treatment

  8. Glasgow Outcome Scale-Extended score

    1 - 8, a higher score indicates better functional recovery from brain injury

    Time frame: 30 days after randomization

  9. Glasgow Outcome Scale-Extended score

    1 - 8, a higher score indicates better functional recovery from brain injury

    Time frame: 90 days after randomization

  10. brain-computer interface accuracy

    measured by electroencephalogram-based brain-computer interface experiment

    Time frame: after 14 days of EA or sham-EA treatment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Thibaut A, Schiff N, Giacino J, Laureys S, Gosseries O. Therapeutic interventions in patients with prolonged disorders of consciousness. Lancet Neurol. 2019 Jun;18(6):600-614. doi: 10.1016/S1474-4422(19)30031-6. Epub 2019 Apr 16. PubMed 31003899 ↗
  • Laureys S, Celesia GG, Cohadon F, Lavrijsen J, Leon-Carrion J, Sannita WG, Sazbon L, Schmutzhard E, von Wild KR, Zeman A, Dolce G; European Task Force on Disorders of Consciousness. Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome. BMC Med. 2010 Nov 1;8:68. doi: 10.1186/1741-7015-8-68. PubMed 21040571 ↗
  • Giacino JT, Ashwal S, Childs N, Cranford R, Jennett B, Katz DI, Kelly JP, Rosenberg JH, Whyte J, Zafonte RD, Zasler ND. The minimally conscious state: definition and diagnostic criteria. Neurology. 2002 Feb 12;58(3):349-53. doi: 10.1212/wnl.58.3.349. PubMed 11839831 ↗
  • Bruno MA, Vanhaudenhuyse A, Thibaut A, Moonen G, Laureys S. From unresponsive wakefulness to minimally conscious PLUS and functional locked-in syndromes: recent advances in our understanding of disorders of consciousness. J Neurol. 2011 Jul;258(7):1373-84. doi: 10.1007/s00415-011-6114-x. Epub 2011 Jun 16. PubMed 21674197 ↗
  • Steriade M, Nunez A, Amzica F. A novel slow (< 1 Hz) oscillation of neocortical neurons in vivo: depolarizing and hyperpolarizing components. J Neurosci. 1993 Aug;13(8):3252-65. doi: 10.1523/JNEUROSCI.13-08-03252.1993. PubMed 8340806 ↗
  • Timofeev I, Grenier F, Bazhenov M, Sejnowski TJ, Steriade M. Origin of slow cortical oscillations in deafferented cortical slabs. Cereb Cortex. 2000 Dec;10(12):1185-99. doi: 10.1093/cercor/10.12.1185. PubMed 11073868 ↗
  • Schiff ND. Recovery of consciousness after brain injury: a mesocircuit hypothesis. Trends Neurosci. 2010 Jan;33(1):1-9. doi: 10.1016/j.tins.2009.11.002. Epub 2009 Dec 1. PubMed 19954851 ↗
  • Giacino JT, Katz DI, Schiff ND, Whyte J, Ashman EJ, Ashwal S, Barbano R, Hammond FM, Laureys S, Ling GSF, Nakase-Richardson R, Seel RT, Yablon S, Getchius TSD, Gronseth GS, Armstrong MJ. Comprehensive systematic review update summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research. Neurology. 2018 Sep 4;91(10):461-470. doi: 10.1212/WNL.0000000000005928. Epub 2018 Aug 8. PubMed 30089617 ↗
  • Li H, Zhang X, Sun X, Dong L, Lu H, Yue S, Zhang H. Functional networks in prolonged disorders of consciousness. Front Neurosci. 2023 Feb 17;17:1113695. doi: 10.3389/fnins.2023.1113695. eCollection 2023. PubMed 36875660 ↗
  • Edlow BL, Claassen J, Schiff ND, Greer DM. Recovery from disorders of consciousness: mechanisms, prognosis and emerging therapies. Nat Rev Neurol. 2021 Mar;17(3):135-156. doi: 10.1038/s41582-020-00428-x. Epub 2020 Dec 14. PubMed 33318675 ↗
  • Rudolph M, Pelletier JG, Pare D, Destexhe A. Characterization of synaptic conductances and integrative properties during electrically induced EEG-activated states in neocortical neurons in vivo. J Neurophysiol. 2005 Oct;94(4):2805-21. doi: 10.1152/jn.01313.2004. Epub 2005 Jul 13. PubMed 16014785 ↗
  • Howell K, Grill E, Klein AM, Straube A, Bender A. Rehabilitation outcome of anoxic-ischaemic encephalopathy survivors with prolonged disorders of consciousness. Resuscitation. 2013 Oct;84(10):1409-15. doi: 10.1016/j.resuscitation.2013.05.015. Epub 2013 Jun 6. PubMed 23747956 ↗
  • Perez P, Valente M, Hermann B, Sitt J, Faugeras F, Demeret S, Rohaut B, Naccache L. Auditory Event-Related "Global Effect" Predicts Recovery of Overt Consciousness. Front Neurol. 2021 Jan 8;11:588233. doi: 10.3389/fneur.2020.588233. eCollection 2020. PubMed 33488494 ↗
  • Threlkeld ZD, Bodien YG, Rosenthal ES, Giacino JT, Nieto-Castanon A, Wu O, Whitfield-Gabrieli S, Edlow BL. Functional networks reemerge during recovery of consciousness after acute severe traumatic brain injury. Cortex. 2018 Sep;106:299-308. doi: 10.1016/j.cortex.2018.05.004. Epub 2018 May 12. PubMed 29871771 ↗
  • Demertzi A, Tagliazucchi E, Dehaene S, Deco G, Barttfeld P, Raimondo F, Martial C, Fernandez-Espejo D, Rohaut B, Voss HU, Schiff ND, Owen AM, Laureys S, Naccache L, Sitt JD. Human consciousness is supported by dynamic complex patterns of brain signal coordination. Sci Adv. 2019 Feb 6;5(2):eaat7603. doi: 10.1126/sciadv.aat7603. eCollection 2019 Feb. PubMed 30775433 ↗

Individual participant data

Plan to share: No — The detailed datasets used and/or analyzed during the current study are available upon reasonable request.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Dec 2026, 35 months after the start.

Of 90 non-industry interventional studies with no phase under Consciousness Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 64. This study's planned 35 months is above that.

Counting every sponsor, half of 95 studies reached it within 19 months; a quarter within 8 and three quarters within 52.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Jan 2026 → Dec 2026 and completion Jan 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2024
First posted
Feb 20, 2024
StartActual
Jan 1, 2024
Primary completionEst.
Dec 31, 2026was Jan 2026
CompletionEst.
Dec 31, 2026was Jan 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 31, 2026→Dec 31, 2026
Nov 18, 2026
Study completion
Jan 31, 2026→Dec 31, 2026
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Primary completion Jan 31, 2026→Dec 31, 2026
    Study completion Jan 31, 2026→Dec 31, 2026
    + 3 other changes: verification date, contact details and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06268236
Lead sponsor
The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Responsible party
Fang Yuan (Principal Investigator, The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine) — Principal investigator
First posted
Feb 20, 2024
Start date
Jan 1, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 18, 2026

Study contacts

Fang Yuan, PhD
Contact
yuanfang@gzucm.edu.cn
+86-20-81887233
Jixiang Chen, PhD
Contact
756337176@qq.com
Fang Yuan, PhD
study director · The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion